GlassScriptPhysician profile
Sunil Bhoyrul
NPI 1366559320
$57,790.71
in general payments reported to CMS, 2019-2025
19 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,484 · 2020: $317 · 2021: $908 · 2022: $3,309 · 2023: $22K · 2024: $16K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Education: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,893 · Travel and Lodging: $7,766 · Food and Beverage: $5,341 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,994.63 |
| Education | $10,762.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,892.60 |
| Travel and Lodging | $7,765.78 |
| Food and Beverage | $5,340.81 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,520.64 | 2021-2025 | Signia, Ligasure, Sonicision |
| Intuitive Surgical, INC. | $16,396.18 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $10,425.74 | 2022-2024 | Echelon; Endopath, Harmonic, Surgicel Nu-Knit |
| Ethicon US, LLC | $1,501.93 | 2019-2025 | Echelon Flex, Harmonic, Echelon; Endopath |
| Allergan, INC. | $1,023.86 | 2019-2022 | |
| Covidien LP | $667.54 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $294.73 | 2021-2025 | Gattex |
| Novo Nordisk INC | $262.02 | 2021-2025 | Wegovy |
| Teleflex LLC | $237.16 | 2023-2025 | Titan Sgs Bailout Chuck, Titan Sgs Standard Gastric Stapler |
| Tela Bio, INC. | $168.96 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $86.80 | 2023 | Phasix Mesh |
| Trevena, INC. | $69.20 | 2021 | |
| Currax Pharmaceuticals LLC | $48.53 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $26.04 | 2022 | |
| Conmed Corporation | $20.34 | 2024 | Airseal |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $14.93 | 2021 | |
| Intra-Sana Laboratories | $13.99 | 2025 | Glycate, Reltone 400 Mg, Reltone 200 Mg |
| Ambu INC. | $12.12 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Bhoyrul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.